SNORA47: A Protein Implicated in Cell Signaling, Neurodegeneration and Inflammation

Target Name: SNORA47

NCBI ID: G677828

SNORA47

Other Name(s): HBI-115 | small nucleolar RNA, H/ACA box 47 | Small nucleolar RNA, H/ACA box 47

SNORA47: A Protein Implicated in Cell Signaling, Neurodegeneration and Inflammation

SNORA47, also known as HBI-115, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of theSnorA family of proteins, which are known for their role in intracellular signaling . SNORA47 has been shown to play a role in a variety of physiological processes, including cell signaling, inflammation, and neurodegeneration. As a result, SNORA47 has potential as a drug target or biomarker for a variety of diseases.

The discovery and characterization of SNORA47 came as a surprise, as it was initially identified as a gene that was not known to encode any protein. However, studies using techniques such as RNA sequencing and mass spectrometry revealed that SNORA47 was indeed a protein that was expressed in various tissues of the body. The protein is highly conserved, with a calculated molecular weight of 47 kDa.

SNORA47 is a member of theSnorA family of proteins, which are known for their role in intracellular signaling. TheSnorA family includes a variety of different proteins, including SNORA1, SNORA2, and SNORA3, which are expressed in various tissues of the body. These proteins are Involved in a variety of signaling pathways, including cell signaling, inflammation, and neurodegeneration.

One of the key functions of SNORA47 is its role in intracellular signaling. The protein is involved in the regulation of various signaling pathways, including the TGF-β pathway, the Wnt pathway, and the Hedgehog pathway. TGF-β is a well-known pathway that is involved in cell signaling, including cell growth, differentiation, and inflammation. The TGF-β pathway is a critical pathway for the development and maintenance of tissues, and it is thought to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

SNORA47 is also involved in the regulation of the Wnt pathway, which is a critical pathway for the development and maintenance of tissues during embryonic development. The Wnt pathway is a signaling pathway that is involved in the regulation of cell proliferation, differentiation, and survival. It is thought to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In addition to its role in intracellular signaling, SNORA47 is also involved in the regulation of cellular processes that are important for tissue function. For example, the protein is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is also involved in the regulation of cell migration, which is the process by which cells move from one location to another in the body.

In addition to its role in intracellular signaling and cellular processes, SNORA47 is also involved in the regulation of neurodegeneration. The protein is thought to be involved in the regulation of neurodegeneration, which is the progressive loss of brain cells that is associated with a variety of diseases, including Alzheimer's disease and Parkinson's disease.

The potential applications of SNORA47 as a drug target or biomarker are significant. Because SNORA47 is involved in the regulation of various signaling pathways that are important for tissue function and development, it is a potential target for a variety of diseases. For example, because SNORA47 is involved in the regulation of neurodegeneration, it may be a potential target for treatments of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In addition, because SNORA47 is involved in the regulation of intracellular signaling, it may be a potential target for a variety of diseases that are characterized by inflammation or cellular processes that are disrupted.

In conclusion, SNORA47 is a protein that is expressed in various tissues of the body and is involved in a variety of physiological processes, including

Protein Name: Small Nucleolar RNA, H/ACA Box 47

The "SNORA47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORA47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets